Free Review Articles on Obesity                                 Metatextbook

Freie Reviews über Adipositas                                 Look here for Journal Homepages




  • Obesity
  • Diabetes mellitus (BASKET)
  • Orlistat
  • Growth hormone
  • Deep brain stimulation
  • Non alcoholic steatohepatosis
  • Adiponectin
  • Leptin
  • RBP4
  • Visfatin
  • Adipokine
  • Resistin
  • Kidney (Chronic renal failure)
  • Bariatric surgery
  • Endocrine disruptor
  • Estrogen
  • Steatohepatosis
  • Insulin resistance
  • Arterial hypertension (BASKET)
  • Ion channel (Sodium)
  • Liddle s syndrome
  • Ion channel (Sodium ENaC)
  • Neoplasia (Carcinogenesis)
  • Interleukin17
  • Inflammation resolution
  • Lipoxin
  • Prostaglandin D2
  • Protectin
  • Resolvin
  • Agouti
  • Db mouse
  • Nutrition (Neuroendocrinology)
  • Neuropeptide Y
  • Krox20 Egr2
  • Arcuate nucleus
  • Paraventricular nuclei
  • Dorsomedial nucleus
  • Ventromedial nucleus
  • Zucker rat
  • Koletsky rat
  • ob ob mouse
  • Otsuka Long Evans Tokushima fatty rat OLETF rat
  • Tubby mouse
  • Autoantibodies Anti Melanocortin 4 receptor
  • Inflammation (BASKET)
  • Inflammation homeostatic
  • Fatty acids (Free)
  • Circadian clock
  • Anorexia nervosa
  • Ghrelin
  • Cachexia (Oncology and BASKET)
  • Prader Willi s syndrome
  • Fructose
  • A Zip F1 mouse
  • Neoplasia (Cancer survivor)
  • Sibutramine
  • Rimonabant
  • Macrophages
  • Atherosclerosis (BASKET)
  • MIF
  • Nr.Year

    OPEN

    Titleusers

    say

    rate

    good

    rate

    bad

    no link

    Citation
    12006The medical complications of obesity.



    +-nlQJM 99(9):565-79 (2006) Malnick SD
    22006Preventing and managing pediatric obesity. Recommendations for family physicians.



    +-nlCan Fam Physician 52():322-8 (2006) Plourde G
    32007Obesity in children.



    +-nlClin Evid (Online) 2007(): (2007) Arteburn DE
    42008Orlistat in the prevention of diabetes in the obese patient.



    +-nlVasc Health Risk Manag 4(2):325-36 (2008) Mancini MC
    52006Vascular risks and management of obesity in children and adolescents.



    +-nlVasc Health Risk Manag 2(2):171-87 (2006) Jolliffe CJ
    62007Pharmacological treatment of the overweight patient.



    +-nlPharmacol Rev 59(2):151-84 (2007) Bray GA
    72008Atherogenic lipid risk factors in men classified as overweight and obese according to the preliminary WHO guidelines for Asians.



    +-nlIndian J Physiol Pharmacol 52(2):205-8 (2008) Nandeesha H
    82009The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.



    +-nlHealth Technol Assess 13(41):1-190, 215-357, iii-iv (2009) Picot J
    92008Obesity: a review of pathogenesis and management strategies.



    +-nlCan J Gastroenterol 22(1):61-8 (2008) Kaila B
    102004Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity.



    +-nlAm J Clin Nutr 79(4):537-43 (2004) Bray GA
    111993Mechanisms by which somatotropin decreases adipose tissue growth.



    +-nlAm J Clin Nutr 58(2 Suppl):287S-295S (1993)
    121992The role of very-low-calorie diets in obesity.



    +-nlAm J Clin Nutr 56(1 Suppl):240S-243S (1992)
    131992Pathophysiology of obesity.



    +-nlAm J Clin Nutr 55(2 Suppl):488S-494S (1992)
    141992A brief overview of human energy metabolism and its relationship to essential obesity.



    +-nlAm J Clin Nutr 55(1 Suppl):242S-245S (1992)
    151979Obesity: adverse effects on health and longevity.



    +-nlAm J Clin Nutr 32(12 Suppl):2723-33 (1979)
    162001Infectobesity: obesity of infectious origin.



    +-nlJ Nutr 131(10):2794S-2797S (2001)
    172005Obesity: prevalence, theories, medical consequences, management, and research directions.



    +-nlJ Int Soc Sports Nutr 2():4-31 (2005) Wilborn C
    182004Monogenic human obesity syndromes.



    +-nlRecent Prog Horm Res 59():409-24 (2004) Farooqi IS
    192004Hypertension and obesity.



    +-nlRecent Prog Horm Res 59():169-205 (2004) Aneja A
    202010Deep brain stimulation compared with bariatric surgery for the treatment of morbid obesity: a decision analysis study.



    +-nlNeurosurg Focus 29(2):E15 (2010) Pisapia JM
    212008Adverse renal consequences of obesity.



    +-nlAm J Physiol Renal Physiol 294(4):F685-96 (2008) Griffin KA
    222005Meta-analysis: surgical treatment of obesity.



    +-nlAnn Intern Med 142(7):547-59 (2005) Maggard MA
    232005Meta-analysis: pharmacologic treatment of obesity.



    +-nlAnn Intern Med 142(7):532-46 (2005) Li Z
    242008Association between depressive symptoms in childhood and adolescence and overweight in later life: review of the recent literature.



    +-nlArch Pediatr Adolesc Med 162(10):981-8 (2008) Liem ET
    252005Overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment.



    +-nlCirculation 111(15):1999-2012 (2005) Daniels SR
    262007Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.



    +-nlClin J Am Soc Nephrol 2(3):550-62 (2007) Wahba IM
    272008Neurophysiological pathways to obesity: below awareness and beyond individual control.



    +-nlDiabetes 57(7):1768-73 (2008) Cohen DA
    282006Influence of obesity on the risk of developing colon cancer.



    +-nlGut 55(2):285-91 (2006) Frezza EE
    292004New thoughts on managing obesity.



    +-nlGut 53(7):1044-53 (2004) Kopelman PG
    302008Clinical review: treatment of pediatric obesity: a systematic review and meta-analysis of randomized trials.



    +-nlJ Clin Endocrinol Metab 93(12):4600-5 (2008) McGovern L
    312008Clinical review: behavioral interventions to prevent childhood obesity: a systematic review and metaanalyses of randomized trials.



    +-nlJ Clin Endocrinol Metab 93(12):4606-15 (2008) Kamath CC
    322008Prevention and treatment of pediatric obesity: an endocrine society clinical practice guideline based on expert opinion.



    +-nlJ Clin Endocrinol Metab 93(12):4576-99 (2008) August GP
    332008Obesity-associated liver disease.



    +-nlJ Clin Endocrinol Metab 93(11 Suppl 1):S74-80 (2008)
    342008Adipocytokines and the metabolic complications of obesity.



    +-nlJ Clin Endocrinol Metab 93(11 Suppl 1):S64-73 (2008) Rasouli N
    352008Obesity in children and adolescents.



    +-nlJ Clin Endocrinol Metab 93(11 Suppl 1):S31-6 (2008)
    362008Update on obesity.



    +-nlJ Clin Endocrinol Metab 93(6):2027-34 (2008) Bessesen DH
    372007Review: Peroxisome proliferator-activated receptor gamma and adipose tissue--understanding obesity-related changes in regulation of lipid and glucose metabolism.



    +-nlJ Clin Endocrinol Metab 92(2):386-95 (2007) Sharma AM
    382005Childhood obesity.



    +-nlJ Clin Endocrinol Metab 90(3):1871-87 (2005) Speiser PW
    392004Childhood obesity.



    +-nlJ Clin Endocrinol Metab 89(9):4211-8 (2004) Miller J
    402004Medical consequences of obesity.



    +-nlJ Clin Endocrinol Metab 89(6):2583-9 (2004) Bray GA
    412001Obesity-related glomerulopathy: an emerging epidemic.



    +-nlKidney Int 59(4):1498-509 (2001)
    422007Evaluation and management of childhood and adolescent obesity.



    +-nlMayo Clin Proc 82(10):1258-64 (2007) Singhal V
    432007Viruses as an etiology of obesity.



    +-nlMayo Clin Proc 82(10):1192-8 (2007) Atkinson RL
    442007Surgery for morbid obesity.



    +-nlPostgrad Med J 83(975):8-15 (2007) Bennett JM
    451988Obesity. Part II--Treatment.



    +-nlWest J Med 149(5):555-71 (1988)
    461988Obesity. Part I--Pathogenesis.



    +-nlWest J Med 149(4):429-41 (1988)
    472007Diseases associated with childhood obesity.



    +-nlAJR Am J Roentgenol 188(4):1118-30 (2007) Choudhary AK
    482007Synopsis of the 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children.



    +-nlCMAJ 176(8):1103-6 (2007) Lau DC
    4920072006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary].



    +-nlCMAJ 176(8):S1-13 (2007) Lau DC
    502008The role of SOCS-3 protein in leptin resistance and obesity.



    +-nlActa Med Indones 40(2):89-95 (2008)
    512009Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review.



    +-nlAm J Nephrol 30(2):140-6 (2009)
    522011Respiratory complications of obesity.



    +-nlArch Bronconeumol 47(5):252-61 (2011)
    532004Dietary supplements for body-weight reduction: a systematic review.



    +-nlAm J Clin Nutr 79(4):529-36 (2004)
    542005Survival advantages of obesity in dialysis patients.



    +-nlAm J Clin Nutr 81(3):543-54 (2005)
    552006Metabolic programming: fetal origins of obesity and metabolic syndrome in the adult.



    +-nlAm J Physiol Endocrinol Metab 291(3):E439-40 (2006)
    562006ABC of obesity. Assessment of obesity and its clinical implications.



    +-nlBMJ 333(7570):695-8 (2006)
    572006ABC of obesity. Management: Part I--behaviour change, diet, and activity.



    +-nlBMJ 333(7571):740-3 (2006)
    582006ABC of obesity. Management: Part III--surgery.



    +-nlBMJ 333(7574):900-3 (2006)
    592006ABC of obesity. Management: part II--drugs.



    +-nlBMJ 333(7572):794-7 (2006)
    602006ABC of obesity. Strategies for preventing obesity.



    +-nlBMJ 333(7575):959-62 (2006)
    612006ABC of obesity. Obesity and cancer.



    +-nlBMJ 333(7578):1109-11 (2006)
    622006ABC of obesity: obesity and vascular disease.



    +-nlBMJ 333(7577):1060-3 (2006)
    632006ABC of obesity. Risk factors for diabetes and coronary heart disease.



    +-nlBMJ 333(7576):1009-11 (2006)
    642006ABC of obesity. Childhood obesity.



    +-nlBMJ 333(7580):1207-10 (2006)
    652006ABC of obesity. Obesity and reproduction.



    +-nlBMJ 333(7579):1159-62 (2006)
    662009Regulation of energy metabolism pathways by estrogens and estrogenic chemicals and potential implications in obesity associated with increased exposure to endocrine disruptors.



    +-nlBiochim Biophys Acta 1793(7):1128-43 (2009)
    672006Tending to the musculoskeletal problems of obesity.



    +-nlCleve Clin J Med 73(9):839-45 (2006)
    682003Prevention of pediatric overweight and obesity.



    +-nlPediatrics 112(2):424-30 (2003)
    692007Assessment of child and adolescent overweight and obesity.



    +-nlPediatrics 120 Suppl 4(-):S193-228 (2007)
    702007Recommendations for prevention of childhood obesity.



    +-nlPediatrics 120 Suppl 4(-):S229-53 (2007)
    712007Recommendations for treatment of child and adolescent overweight and obesity.



    +-nlPediatrics 120 Suppl 4(-):S254-88 (2007)
    722009Spectrum and management of hypertriglyceridemia among children in clinical practice.



    +-nlPediatrics 123(2):458-65 (2009)
    732007Metabolic liver disease of obesity and role of adipose tissue in the pathogenesis of nonalcoholic fatty liver disease.



    +-nlWorld J Gastroenterol 13(26):3540-53 (2007)
    742007Treatment of obesity.



    +-nlMayo Clin Proc 82(1):93-101; quiz 101-2 (2007)
    752007Microvascular dysfunction in obesity: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension.



    +-nlPhysiology (Bethesda) 22(-):252-60 (2007)
    762010Sympathetic activation in obesity: a noninnocent bystander.



    +-nlHypertension 56(3):338-40 (2010)
    772002Obesity hypertension in children: a problem of epidemic proportions.



    +-nlHypertension 40(4):441-7 (2002)
    782010Obesity, sympathetic overdrive, and hypertension: the leptin connection.



    +-nlHypertension 55(4):844-5 (2010)
    792007Hypoadiponectinemia: a novel link between obesity and hypertension?



    +-nlHypertension 49(6):1217-9 (2007)
    802008Should we target the sympathetic nervous system in the treatment of obesity-associated hypertension?



    +-nlHypertension 51(2):168-71 (2008)
    812004Overview: obesity: what does it have to do with kidney disease?



    +-nlJ Am Soc Nephrol 15(11):2768-72 (2004)
    822004Obesity-initiated metabolic syndrome and the kidney: a recipe for chronic kidney disease?



    +-nlJ Am Soc Nephrol 15(11):2775-91 (2004)
    832004The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.



    +-nlJ Am Soc Nephrol 15(11):2792-800 (2004)
    842003After all those fat years: renal consequences of obesity.



    +-nlNephrol Dial Transplant 18(12):2471-4 (2003)
    852008Why is obesity associated with osteoarthritis? Insights from mouse models of obesity.



    +-nlBiorheology 45(3-4):387-98 (2008)
    862010Endoplasmic reticulum stress and inflammation in obesity and diabetes.



    +-nlCirc Res 107(5):579-91 (2010)
    872007Cardiac energy metabolism in obesity.



    +-nlCirc Res 101(4):335-47 (2007)
    882007Adiposity and cardiovascular disorders: disturbance of the regulatory system consisting of humoral and neuronal signals.



    +-nlCirc Res 101(1):27-39 (2007)
    892007Leptin signaling and obesity: cardiovascular consequences.



    +-nlCirc Res 101(6):545-59 (2007)
    902011Biology of obesity: lessons from animal models of obesity.



    +-nlJ Biomed Biotechnol 2011(-):197636 (2011)
    912006Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss.



    +-nlArterioscler Thromb Vasc Biol 26(5):968-76 (2006)
    922010Epithelial Na+ channel (ENaC), hormones, and hypertension.



    +-nlJ Biol Chem 285(31):23527-31 (2010)
    932010The possible role of IL-17 in obesity-associated cancer.



    +-nlScientificWorldJournal 10(-):2265-71 (2010)
    942010Resolution of adipose tissue inflammation.



    +-nlScientificWorldJournal 10(-):832-56 (2010)
    952006Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.



    +-nlPhilos Trans R Soc Lond B Biol Sci 361(1471):1159-85 (2006)
    962006Genetics of obesity.



    +-nlPhilos Trans R Soc Lond B Biol Sci 361(1471):1095-105 (2006) O'Rahilly S
    972008Role of body fat distribution and the metabolic complications of obesity.



    +-nlJ Clin Endocrinol Metab 93(11 Suppl 1):S57-63 (2008)
    982008Lifestyle and pharmacological approaches to weight loss: efficacy and safety.



    +-nlJ Clin Endocrinol Metab 93(11 Suppl 1):S81-8 (2008)
    992008Bariatric surgery: risks and rewards.



    +-nlJ Clin Endocrinol Metab 93(11 Suppl 1):S89-96 (2008)
    1002009Melanocortin-4-receptor autoantibodies: a new player in obesity.



    +-nlJ Clin Endocrinol Metab 94(3):757-9 (2009) Mohan C
    1012010Homeostatic inflammation, an emerging concept.



    +-nlEndocr J 57(8):657-8 (2010)
    1022008Obesity and free fatty acids.



    +-nlEndocrinol Metab Clin North Am 37(3):635-46, viii-ix (2008)
    1032009Pediatric obesity: etiology and treatment.



    +-nlEndocrinol Metab Clin North Am 38(3):525-48 (2009)
    1042010Metabolism and circadian rhythms--implications for obesity.



    +-nlEndocr Rev 31(1):1-24 (2010)
    1052011Ghrelin biology and its role in weight-related disorders.



    +-nlDiscov Med 11(61):521-8 (2011)
    1062011Genetic approaches to understanding human obesity.



    +-nlJ Clin Invest 121(6):2080-6 (2011)
    1072011Adipose tissue remodeling and obesity.



    +-nlJ Clin Invest 121(6):2094-101 (2011)
    1082011Inflammatory links between obesity and metabolic disease.



    +-nlJ Clin Invest 121(6):2111-7 (2011)
    1092010Metabolic effects of fructose and the worldwide increase in obesity.



    +-nlPhysiol Rev 90(1):23-46 (2010)
    1102008Cardiac remodeling in obesity.



    +-nlPhysiol Rev 88(2):389-419 (2008)
    1112010JNK1 and IKKbeta: molecular links between obesity and metabolic dysfunction.



    +-nlFASEB J 24(8):2596-611 (2010)
    1122007The obesity-cancer link: lessons learned from a fatless mouse.



    +-nlCancer Res 67(6):2391-3 (2007)
    1132006Obesity in childhood and adolescence: evidence based clinical and public health perspectives.



    +-nlPostgrad Med J 82(969):429-37 (2006)
    1142003Principles and practices in the management of obesity.



    +-nlAm J Respir Crit Care Med 168(3):274-80 (2003)
    1152006Pharmacological treatment of obesity.



    +-nlArq Bras Endocrinol Metabol 50(2):377-89 (2006)
    1162009Genetic variants influencing effectiveness of weight loss strategies.



    +-nlArq Bras Endocrinol Metabol 53(2):129-38 (2009)
    1172009Translational research into gut microbiota: new horizons in obesity treatment.



    +-nlArq Bras Endocrinol Metabol 53(2):139-44 (2009)
    1182009The brain is the conductor: diet-induced inflammation overlapping physiological control of body mass and metabolism.



    +-nlArq Bras Endocrinol Metabol 53(2):151-8 (2009)
    1192009Infeccions as the etiology for obesity.



    +-nlArq Bras Endocrinol Metabol 53(2):159-64 (2009)
    1202009Impact of adiposity on immunological parameters.



    +-nlArq Bras Endocrinol Metabol 53(2):183-9 (2009)
    1212009Adiposity in childhood cancer survivors: insights into obesity physiopathology.



    +-nlArq Bras Endocrinol Metabol 53(2):190-200 (2009)
    1222009Protective roles of adiponectin in obesity-related fatty liver diseases: mechanisms and therapeutic implications.



    +-nlArq Bras Endocrinol Metabol 53(2):201-12 (2009)
    1232009Epidemiological and molecular mechanisms aspects linking obesity and cancer.



    +-nlArq Bras Endocrinol Metabol 53(2):213-26 (2009)
    1242009Metabolic disturbances linked to obesity: the role of impaired tissue perfusion.



    +-nlArq Bras Endocrinol Metabol 53(2):238-45 (2009)
    1252009Management of obesity in adolescents: state of art.



    +-nlArq Bras Endocrinol Metabol 53(2):252-61 (2009)
    1262009The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions.



    +-nlArq Bras Endocrinol Metabol 53(2):262-70 (2009)
    1272009Emerging drugs for obesity therapy.



    +-nlArq Bras Endocrinol Metabol 53(2):271-80 (2009)
    1282011Bariatric surgery.



    +-nlDtsch Arztebl Int 108(20):341-6 (2011)
    1292006The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies.



    +-nlCMAJ 174(9):1293-9 (2006)
    130200410: Management of obesity.



    +-nlMed J Aust 180(9):474-80 (2004)
    1312011The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review.



    +-nlHealth Technol Assess 15(2):1-182 (2011)
    1322009Rimonabant for the treatment of overweight and obese people.



    +-nlHealth Technol Assess 13 Suppl 3(-):13-22 (2009)
    1332009Rimonabant: an antagonist drug of the endocannabinoid system for the treatment of obesity.



    +-nlPharmacol Rep 61(2):217-24 (2009)
    1342007Adolescent overweight and obesity--how best to manage in the general practice setting.



    +-nlAust Fam Physician 36(8):606-12 (2007)
    1352010Obesity in children & adolescents.



    +-nlIndian J Med Res 132(5):598-607 (2010)
    1362010The adverse effects of obesity on conception and implantation.



    +-nlReproduction 140(3):347-64 (2010)
    1372007Developmental programming of obesity in mammals.



    +-nlExp Physiol 92(2):287-98 (2007)
    1382005The neurobiology of human obesity.



    +-nlExp Physiol 90(5):673-82 (2005)
    1392005Role of leptin in obesity-related hypertension.



    +-nlExp Physiol 90(5):683-8 (2005)
    1402009Medical management of obesity and its complications.



    +-nlAnn Acad Med Singapore 38(1):22-7 (2009)
    1412009Endocrine disrupters as obesogens.



    +-nlMol Cell Endocrinol 304(1-2):19-29 (2009)
    1422009Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome.



    +-nlMol Cell Endocrinol 304(1-2):49-54 (2009)
    1432010Hormones and cytokines in childhood obesity.



    +-nlIndian Pediatr 47(10):829-39 (2010)
    1442010Mediators of inflammation in obesity and its comorbidities.



    +-nlMediators Inflamm 2010(-):- (2010)
    1452010The role of adipose tissue and adipokines in obesity-related inflammatory diseases.



    +-nlMediators Inflamm 2010(-):802078 (2010)
    1462010Chronic inflammation in obesity and the metabolic syndrome.



    +-nlMediators Inflamm 2010(-):- (2010)
    1472010Inflammatory mediators and insulin resistance in obesity: role of nuclear receptor signaling in macrophages.



    +-nlMediators Inflamm 2010(-):219583 (2010)
    1482010Functional food targeting the regulation of obesity-induced inflammatory responses and pathologies.



    +-nlMediators Inflamm 2010(-):367838 (2010)
    1492010Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review.



    +-nlMediators Inflamm 2010(-):513948 (2010)
    1502010Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells.



    +-nlMediators Inflamm 2010(-):174341 (2010)
    1512010Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients.



    +-nlMediators Inflamm 2010(-):364957 (2010)
    1522010Macrophage migration inhibitory factor: critical role in obesity, insulin resistance, and associated comorbidities.



    +-nlMediators Inflamm 2010(-):610479 (2010)
    1532008Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.



    +-nlNat Rev Mol Cell Biol 9(5):367-77 (2008)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.